VKH
PLSE icon

Virtu KCG Holdings’s Pulse Biosciences PLSE Stock Holding History

Virtu KCG Holdings’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$240K Sell
6,961
-3,104
-31% -$85.3K 0.01% 1952
2017
Q1 		$205K Buy
+10,065
New +$137K 0.01% 2393

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TF
TIAA FSB Jacksonville, Florida $27.6B AUM 14.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu KCG Holdings's PLSE Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Pulse Biosciences (PLSE) stake by 31% in Q2 2017, selling an estimated $85.3K and leaving 6,961 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #1952.

Virtu KCG Holdings first reported a position in PLSE in Q1 2017 and has held it in 2 quarters since. 49 funds tracked by Wall St. Rank hold PLSE as of Q2 2017.

  • Virtu KCG Holdings held 6,961 shares of Pulse Biosciences worth $240K as of Q2 2017.
  • Virtu KCG Holdings sold 3,104 Pulse Biosciences shares in Q2 2017, an estimated $85.3K.
  • Pulse Biosciences made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1952 holding.
  • Virtu KCG Holdings first reported a position in Pulse Biosciences in Q1 2017 and has held it in 2 quarters since.
  • 49 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.